pharma
Trump’s drug pricing reforms lack bite
February 12, 2018Sales and Marketing Drug pricing, President trump, Trump, biotech, drugs, pharma, pharmaceutical
President Trump’s rhetoric leading up to his election had the pharmaceutical industry very worried – his often quoted line about …
Boehringer terminates Alzheimer’s candidate after Phase 2 failure
February 12, 2018Research and Development, Sales and Marketing Alzheimer's, Boehringer Ingelheim, dementia, pharma
Boehringer Ingelheim has announced its intention to halt development of its candidate BI 409306 in the treatment of Alzheimer’s after …
MannKind entices Lilly VP to CMO role
February 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Mannkind, biotech, drugs, pharma, pharmaceutical
MannKind, the California-based biotech, announced that David Kendall would be joining its team as Chief Medical Officer and would be …
SFO bribery investigation into GSK opens old wounds
February 9, 2018Medical Communications GSK, biotech, drugs, pharma, pharmaceutical
A small titbit of information was buried within GSK’s financials this week, which threatens to bring up old news that …
Top Ten most popular articles on Pharmafile.com this week
February 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Allergan, Antibiotics, Avycaz, Elastagen, FDA, GSK, India, J&J, JJ, Nektar Therapeutics, Novartis, Theravance, artificial intelligence, pharma
It’s top ten time again. This week, among our most popular stories was the worrying news that, accoridng to research …
Fujifilm partners with Takeda, stepping into regenerative medicine
February 9, 2018Medical Communications, Research and Development Fujifilm, Takeda, biotech, drugs, pharma, pharmaceutical
Fujifilm has been steadily building up its regenerative medicines, with several acquisitions of companies that hold expertise in the area …
FDA expands J&J Zytiga combo’s indication to include castration-sensitive prostate cancer
February 9, 2018Medical Communications, Sales and Marketing Cancer, FDA, J&J, JJ, Janssen, Johnson & Johnson, Zytiga, pharma
Johnson & Johnson has announced that Zytiga (abiraterone acetate) in combination with prednisone has been awarded FDA approval in the …
Migraine drug bad news hits a weakened Teva
February 9, 2018Medical Communications, Sales and Marketing CGRP, Teva, biotech, drugs, pharma, pharmaceutical
The cacophony of bad news that Teva has received in 2017 really needs no retelling, anyone following the story of …
New Year, new goals
February 8, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer Research UK, Chiesi, EMA, FDA, Genetic Alliance, pharma
With the New Year begun in earnest, Pharmafocus speaks to a range of players in pharma and the life sciences …
Dr Reddy’s hit by yet another recall, of 80,000+ bottles
February 8, 2018Sales and Marketing Dr Reddy's, FDA, biotech, drugs, pharma, pharmaceutical
Dr Reddy’s Laboratories problem with ensuring products reach the market at a quality the FDA deems acceptable is no secret …
FDA approves Gilead’s Biktarvy for HIV as Viiv Healthcare launches patent lawsuit
February 8, 2018Sales and Marketing Biktarvy, FDA, GSK, Gilead, HIV, Pfizer, Shionogi, US, ViiV Healthcare, descovy, pharma
Gilead has announced that its daily single-tablet therapy Biktarvy has received FDA approval for HIV-1 infection.
Novartis tastes own medicine, Advair generic delayed
February 8, 2018Sales and Marketing FDA, Novartis, biotech, drugs, pharma, pharmaceutical
Novartis had not been frontrunner to receive approval for its generic version of GSK’s Advair – lagging behind Mylan’s generic …
Theravance seals potential $1bn deal with J&J
February 8, 2018Sales and Marketing Johnson & Johnson, Theravance Biopharma, biotech, drugs, pharma, pharmaceutical
The JAK inhibitor field is beginning to heat up – AbbVie is soon to enter Phase 3 with its predicted …
Biogen halts Tysabri trial after failure in acute ischemic stroke
February 8, 2018Research and Development Biogen, Tysabri, multiple sclerosis, pharma, stroke, trial failure
Biogen has halted its investigation into the efficacy of its humanised monoclonal antibody Tysabri (natalizumab) in the treatment of acute …
CEO gets the axe: Arcturus relieve Payne of position
February 7, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Arcturus, biotech, drugs, pharma, pharmaceutical
Early in February, Arcturus Therapeutics revealed that it had let its CEO, Joseph Payne, go and had replaced him as …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
